131

Gallbladder intraepithelial neoplasia tissue array, including TNM, stage and pathology grade, 45 cases/ 80 cores, replacing BIC44011

Gangliocytoma and paraganglioma tissue array, 40 cases/80 cores

Gastric adenocarcinoma tissue array (27 cases) and esophagogastric junction carcinoma (4 cases).

Gastric adenocarcinoma tissue array (28 cases) and esophagogastric junction carcinoma (6 cases).

Gastric adenocarcinoma tissue array (30 cases), tumor, NAT.

Gastric adenocarcinoma tissue array (40 cases), NAT.

Gastric adenocarcinoma tissue array (40 cases), tumor, matched NAT.

Gastric adenocarcinoma tissue array (90 cases), normal adjacent tissue (8 cases), Other carcinoma (12 cases)

Gastric adenocarcinoma tissue array (92 cases), containing tubular adenocarcinoma (30 cases), mucinous adenocarcinoma (31 cases), signet ring cell carcinoma (30 cases)

Gastric adenocarcinoma tissue array(20 cases), tumor and matched NAT.

Gastric adenocarcinoma tissue array(30 cases), tumor and matched NAT.

Gastric adenocarcinoma tissue array(40 cases), 1 core/case.

Gastric adenocarcinoma tissue array, 32 cases.

Gastric adenocarcinoma tissue array,90 cases, tumor and matched normal adjacent tissue

Gastric adenocarcinoma tissue array,90 cases, tumor and matched normal adjacent tissue with survival information

Gastric adenocarcinoma, 80 cases, tumor and NAT.

gastric adenocarcinoma, 90 cases, 90 cases have tumor and NAT.

gastric adenocarcinoma, 90 cases, tumor and NAT.

Gastric adenocarcinoma, 96 cases, 82 cases have tumor and NAT.

Gastric adenocarcinoma, 96 cases, 84 cases have tumor and NAT.

Gastric adenocarcinoma,90 cases, tumor and matched NAT.

Gastric cancer and normal gastric tissue array, including TNM, clinical stage and pathology grade, 48 cases/48 cores, replacing ST483d

Gastric cancer from gastric cardia, gastric fundus, gastric body and gastric antrum, with matched cancer adjacent tissue array, including TNM, clinical stage and pathology grade, 104 cases/ 208...

Gastric cancer tissue array, 130 cases/390 cores

Gastric carcinoma tissue array (31 cases), containing squamous cell carcinoma (6 cases), tubular adenocarcinoma (6 cases), mucinous adenocarcinoma (6 cases), signet ring cell carcinoma (7 caes) and...

Gastric carcinoma tissue array(31 cases). NAT.

gastric carcinoma, 45 cases

gastric carcinoma, 75 cases.

Gastric carcinoma, gastritis and intestinal metaplasia tissue array, including TNM, clinical stage and pathology grade, 80 cases/80 cores, replacing IC00011b

Gastric cardia disease spectrum (cardia cancer progression) tissue array, 80 cases/80 cores

Gastric fundus cancer tissue array with normal or adjacent gastric fundus tissue as control, including TNM, clinical stage and pathology grade, 30 cases/ 60 cores

Gastric mucosa intestinal metaplasia tissue array, 80 cases/80 cores, replacing ST8017

Gastric ulcerative tissue array with normal gastric tissue, 14 cases/24 cores, replacing BB01011

Gastroesophageal junction (GEJ) cancer tissue array, including TNM, clinical stage and pathology grade, 94 cases/94 cores

Gastroesophageal junction adjacent tissue array matched CA301-1, 30 cases/ 30 cores

Gastroesophageal junction cancer tissue array, including TNM, clinical stage and pathology grade, 30 cases/ 30 cores

Gastroesophageal junctional cancer tissue array, 65 cases and matched normal adjacent tissue, with survival data

Gastrointestinal stromal tumor tissue array, 24 cases/48 cores

Gastrointestinal stromal tumors (GISTs) array, 80 cases/80 cores��� replacing GIST801

Gastrointestinal tract interstitialoma tissue array, including TNM and clinical stage and IHC markers (CD117) results, 96 cases/96 cores

Gastroscope biopsy tissue array, 24 cases/24 cores

GI (oral cavity, esophagus, stomach, small intestine, pancreas, liver, gall bladder, appendix, colon, rectum) Stage IV cancer tissue array, including TNM, pathology grade and clinical stage, 80...

GI cancer (esophageal, gastric, liver, gall bladder, large intestine and small intestine carcinoma) tissue array, 48 cases/96 cores

GI cancer (gastric, colon and rectal carcinoma) tissue array, 24 cases/48 cores

GIST DOG1 molecule IHC control array, 3 cases/6 cores

Goiter and thyroiditis (Hashimoto disease) tissue array, 80 cases/80 cores

HBV(+) and HBV(-) noncancerous liver tissue array, 80 cases/ 160 cores

Head & Neck cancer tissue array with unmatched normal adjacent tissues, 24 cases/48 cores with stage and grade data

Head & Neck cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases/24 cores

Head and neck cancer tissue array with adjacent normal head and neck tissue, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing HN241

Head and neck cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing HN242

Head and neck cancer with normal tissue array, including TNM, clinical stage and pathology grade, 48 cases/48 cores, replacing HN483

Head and neck cancer with tongue tissue array, including pathology grade, TNM, clinical stage and IHC marker (P16), 80 cases/80 cores, replacing HN803e

Head and neck disease tissue array (with inflammatory, benign and malignant tumor tissue), 102 cases/102 cores

Head and neck disease tissue array, 18 cases/18 cores

Head and neck disease tissue array, 48 cases/96 cores

Head and neck squamous cell carcinoma tissue array, including TNM, clinical stage and pathology grade, 40 cases/80 cores, replaced by HN801b

Head and neck squamous cell carcinoma tissue array, including TNM, clinical stage and pathology grade, 40 cases/80 cores, replacing HN801a

Head and Neck tumor and normal tissue array, including TNM, clinical stage and pathology grade, 27 cases/81 cores, replaced by HN811a

Head and neck tumor tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 27 cases/81 cores, replacing HN811

Heart disease and normal tissue array, replacing BC30011, 18 cases/36 cores

Heart disease spectrum (heart tumor progression) tissue array, 50 cases/100 cores

Heart tumor test tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 6 cases/24 cores

Heart tumor tissue array, with normal heart tissue, including TNM, 6 cases/24 cores, replacing T301

Hepatic disease spectrum (liver cancer progression) tissue array, 103 cases/208 cores

Hepatic tissue, hepatitis and hepatic cirrhosis tissue array, 80 cases/80 cores, eplacing LV805b

Hepatitis B liver cancer and cancer adjacent tissue array, including TNM, clinical stage and pathology grade, 140 cases/140 cores

Hepatocarcinoma tissue array, 47 cases. Tumor and matched normal adjacent tissue

Hepatocarcinoma, 20 cases. Tumor and matched NAT.

Hepatocellular carcinoma and normal tissue array with stage and grade information, 24 cases/72 cores

Hepatocellular carcinoma and normal tissue array, including pathology grade, TNM, clinical stage, HBV and HCV infection information, 30 cases/80 cores, replacing LV8013a

Hepatocellular carcinoma and normal tissue array, including pathology grade, TNM, stage���HBV and HCV infection information, 30 cases/80 cores, replaced by LV8013b

Hepatocellular carcinoma and normal tissue array, with stage, TNM and grade, 80 cases/80 cores, replaced by LV809a

Hepatocellular carcinoma array with liver tissue, including TNM, clinical stage and pathology grade, 80 cases/80 cores, replacing LV809

Hepatocellular carcinoma tissue array with matched adjacent liver tissue, including TNM, pathology grade and clinical stage, 16 cases/48 cores, replacing LV487

Hepatocellular carcinoma tissue array with matched normal cancer adjacent tissue, 55 cases/63 cores

Hepatocellular carcinoma tissue array, 100 cases. Sclerosing hepatocellular carcinoma, 5 cases. Liver cirrhosis, 20 cases.

Hepatocellular carcinoma tissue array, 13 cases, tumor and matched normal adjacent tissue

Hepatocellular carcinoma tissue array, 23 cases. Intrahepatic cholangiocellular carcinoma, 2 cases. Tumor and normal adjacent tissue

Hepatocellular carcinoma tissue array, 25 cases, intrahepatic cholangiocellular carcinoma, 1 case, hepatic adenoma 2 cases, poorly differentiated carcinoma 1 cases

Hepatocellular carcinoma tissue array, 30 cases. Tumor and matched normal adjacent tissue

Hepatocellular carcinoma tissue array, 31 cases, tumor and matched normal adjacent tissue

Hepatocellular carcinoma tissue array, 31 cases. Tumor and matched normal adjacent tissue

Hepatocellular carcinoma tissue array, 32 cases

Hepatocellular carcinoma tissue array, 32 cases.

Hepatocellular carcinoma tissue array, 38 cases.

Hepatocellular carcinoma tissue array, 55 cases. 51 cases have tumor and matched normal adjacent tissue, 4 cases have tumor or NAT.

Hepatocellular carcinoma tissue array, 56 cases. Tumor and matched NAT.

Hepatocellular carcinoma tissue array, 62 cases

Hepatocellular carcinoma tissue array, 95 cases. Tumor and normal adjacent tissue.

Hepatocellular carcinoma tissue array, including TNM and pathology grade, 48 cases/96 cores

Hepatocellular carcinoma tissue array, including TNM, clinical stage and pathology grade, 23 cases/63 cores, replacing BS03013

Hepatocellular carcinoma tissue microarray, 40 cases/60 cores, progression clincal stage I - IV.

Hepatocellular carcinoma, 30 cases. Tumor and matched NAT.

Hepatocellular carcinoma, 32 cases. Tumor and NAT.

Hepatocellular carcinoma, 49 cases. Tumor and NAT.

Hepatocellular carcinoma, 75 cases. Tumor and matched NAT.

Hepatocellular carcinoma, 90 cases.

Hepatocellular carcinoma, 90 cases. Tumor and NAT.